{
  "id": "d6e720d595d549ed",
  "title": "STAT+: What to expect from Gossamer Bio\u2019s late-stage lung disease study",
  "description": "Gossamer Bio will be reporting the outcome of a late-stage study in pulmonary arterial hypertension. Here's what to know.",
  "content": "Gossamer Bio will be reporting the outcome of a late-stage study in pulmonary arterial hypertension. Here's what to know.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/19/gossamer-bio-promis-neurosciences/?utm_campaign=rss",
  "published_at": "2026-02-19T11:30:00+00:00",
  "fetched_at": "2026-02-20T00:27:32.210173+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "STAT+: What to expect from Gossamer Bio\u2019s late-stage lung disease study",
    "description": "Gossamer Bio will be reporting the outcome of a late-stage study in pulmonary arterial hypertension. Here's what to know.",
    "url": "https://www.statnews.com/2026/02/19/gossamer-bio-promis-neurosciences/?utm_campaign=rss",
    "published": "2026-02-19T11:30:00+00:00",
    "source": "STAT"
  }
}